Hutch News

Hutch News

Stories tagged 'HIV transmission'

A voice for HIV cure

As researchers work toward a cure, advocate Tranisha Arzah keeps the focus on community

Nov. 29, 2017 | By Mary Engel / Fred Hutch News Service

Born with HIV, Tranisha Arzah joined the community advisory board for the Fred Hutch-based cure research group defeatHIV to "see if I could get other women involved and make sure they have a voice.”

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

Aug. 11, 2016

Dr. Amit Sharma receives Pathway to Independence Award; Dr. Phil Greenberg publishes T-cell findings; Dr. Yanghee Woo chosen for early-career hematology training program

View story >

A voice for HIV cure: Scientists, activists gather for Hutch conference

Scientists, activists gather for Hutch conference on gene therapy and hope for an HIV cure

Aug. 25, 2014 | By Mary Engel / Fred Hutch News Service

Scientists, activists gather for Hutch conference on gene therapy and hope for an HIV cure.

View story >

Overbaugh wins scientific leadership award

Julie Overbaugh of the Human Biology Division receives tribute, honorarium from Drexel University’s Institute for Women’s Health and Leadership

Aug. 8, 2011

The Fred Hutchinson Cancer Research Center Human Biology Division’s Dr. Julie Overbaugh is the recipient of the 2011 Marion Spencer Fay Award from Drexel University College of Medicine’s Institute for Women's Health and Leadership.

View story >

Initiation of antiretroviral treatment protects partners from HIV infection

Supported by SCHARP’s data management, HIV Prevention Trials Network shows 96 percent reduction in HIV transmission to uninfected sexual partners

May 23, 2011

Men and women infected with HIV reduced the risk of transmitting the virus to their sexual partners by starting oral antiretroviral therapy, according to findings from a large multinational clinical study conducted by the HIV Prevention Trials Network, a global partnership dedicated to reducing the transmission of HIV through biomedical, behavioral, and structural interventions.

View story >

Six-month drug regimen cuts HIV risk for breastfeeding infants

SCHARP data shows longer nevirapine treatment reduces infection by half for babies with HIV-infected mothers, 75 percent for infants of untreated moms

March 14, 2011

Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented March 2 at the Retroviruses and Opportunistic Infections conference in Boston.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.